Shamila S. Gunatilleke

Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51

Michelle R. Arkin, Joseph Mulvaney, Jiri Gut, 2012, PLoS neglected tropical diseases.

Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation.

A. Barrios, Shamila S. Gunatilleke, 2006, Journal of medicinal chemistry.

Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target

A. Burlingame, J. Taunton, J. Gut, 2013, Beilstein journal of organic chemistry.

Tuning the Au(I)-mediated inhibition of cathepsin B through ligand substitutions.

A. Barrios, Shamila S. Gunatilleke, 2008, Journal of inorganic biochemistry.

A high throughput drug screen for Entamoeba histolytica identifies a new lead and target

M. Arkin, J. McKerrow, S. Reed, 2012, Nature Medicine.

Inhibition of cathepsin B by Au(I) complexes: a kinetic and computational study

J. Mccammon, A. Barrios, Shamila S. Gunatilleke, 2008, JBIC Journal of Biological Inorganic Chemistry.

Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents.

J. McKerrow, M. Cameron, W. Roush, 2013, Journal of medicinal chemistry.

Tirandamycin biosynthesis is mediated by co-dependent oxidative enzymes

D. Sherman, Shengying Li, Y. Anzai, 2011, Nature chemistry.

R-Configuration of 4-Aminopyridyl-Based Inhibitors of CYP51 Confers Superior Efficacy Against Trypanosoma cruzi.

J. McKerrow, M. Cameron, W. Roush, 2014, ACS medicinal chemistry letters.